Par Committee seeks creation of separate drug controller for AYUSH medicines
New Delhi, Apr 5 : Par Committee seeks creation of separate drug controller for AYUSH medicines A parliamentary committee today sought creation of a separate drug controller for AYUSH medicines…
Maharashtra: 20 specialists found to have fake degrees, 80 more under scanner
MUMBAI: The licences of 20 specialists in the medical profession in the state, including surgeons, paediatricians, radiologists and gynaecologists, have been suspended for fraudulently obtaining post-graduation degrees by paying an…
MTaI suggests gradual rollout of public procurement guidelines
New Delhi: The Medical Technology Association of India (MTaI) on Thursday said the Department of Pharmaceuticals should prepare a road map for phased implementation of guidelines on public procurement of…
India may soon lead the world in organ donation campaign around the world: Dr Naresh Trehan
Shahid Akhter, editor, ETHealthworld spoke to Dr Naresh Trehan, Chairman & Managing Director, Medanta, to know about Medanta’s initiative and interest in furthering the cause of organ donation in the…
Market Now: Nifty Pharma index down; Dr Reddy’s Labs, Biocon top drags
NEW DELHI: Pharma stocks Dr. Reddy’s Laboratories (down 1.27 per cent), Biocon (down 0.76 per cent) and Lupin (down 0.70 per cent) were trading in the red during afternoon trade…
Drugs sold sans regulator’s nod, safety studies
In a shocking case which has come to light of the Union health ministry, domestic companies have been manufacturing and marketing ‘harmful’ medicines, without conducting studies to establish their safety…
Roche launches new lung, bladder cancer drug in India
New Delhi: Global pharma major Roche today said it has launched monoclonal antibody atezolizumab under the brand name Tecentriq in India for treatment of lung and bladder cancer. Tecentriq has…
Want to reach more patients: Roche India MD
Mumbai: Roche, the world’s largest biotech company with blockbusters like cancer drug Herceptin and haemophilia medicine Hemlibra, has drawn up a blueprint for the Indian market that includes collaboration with…
Rakesh Jhunjhunwala questions Fortis deal with Manipal
NEW DELHI: Ace investor Rakesh Jhunjhunwala questioned the recent deal struck by TPG-backed Manipal Hospitals to acquire control of Fortis Healthcare’s hospitals and its SRL Diagnostics unit, giving public expression…
Man misdiagnosed with HIV sues hospital, receives 1 lakh in compensation
KOLKATA: A court in West Bengal ordered a private hospital to give a compensation of one lakh rupees to Swapan Sahu (name changed) after an error wrongfully diagnosed him with…
